Current role
Biotechnology · Healthcare
Board Member
2021-11-08–present
Samuel Wadsworth, Ph.D.
Board Member
Precision Biosciences Inc (DTIL)Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsAbout Samuel Wadsworth, Ph.D.
Samuel Wadsworth, Ph.D. is recorded as Board Member at Precision Biosciences Inc (DTIL) since June 4, 2024. Precision Biosciences Inc reported in an 8-K filed January 29, 2025 that Samuel Wadsworth, Ph.D. resigned as Board of Directors, effective January 23, 2025. Precision Biosciences Inc reported in an 8-K filed June 10, 2024 that Samuel Wadsworth, Ph.D. was appointed Class II director, effective June 4, 2024. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Naresh Tanna (CFO), Alex Kelly (COO and Chief Accounting Officer) and 7 others.
“On January 23, 2025, Sam Wadsworth, Ph.D., notified Precision BioSciences, Inc. (the “Company”) of his intention to retire from service on company boards and resigned from the Company’s Board of Directors.”
“Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. were elected as Class II directors, and Item 2, Item 3, and Item 4 were approved.”
Affiliation history
-
Current
2024-06-04–present
-
2021-11-08–2025-01-23
Company network
Leadership on record at Precision Biosciences Inc
- Matthew Kane CEO
- Naresh Tanna CFO
- Alex Kelly COO, Chief Accounting Officer
- Dario Scimeca General Counsel
- Mei Burris Chief Accounting Officer
- Shane Barton Chief Accounting Officer
- Geno Germano Board Member
- Melinda Brown Board Member
- Michael Amoroso Board Member
- Samuel Wadsworth Board Member